WVE
Wave Life Sciences Ltd
NASDAQ: WVE · HEALTHCARE · BIOTECHNOLOGY
$7.05
-6.25% today
Updated 2026-04-29
Market cap
$1.36B
P/E ratio
—
P/S ratio
18.89x
EPS (TTM)
$-1.05
Dividend yield
—
52W range
$5 – $22
Volume
4.6M
Wave Life Sciences Ltd (WVE) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0.00 | $152000.00 | $1.49M | $3.70M | $14.41M | $15.98M | $20.08M | $40.96M | $3.65M | $113.31M | $108.30M | $42.73M |
| Revenue growth (YoY) | — | — | — | +877.0% | +149.4% | +289.1% | +10.9% | +25.6% | +104.0% | -91.1% | +3005.1% | -4.4% | -60.5% |
| Cost of revenue | $4.61M | $2.40M | $9.06M | $393000.00 | $79.31M | $134.43M | $175.43M | $130.94M | $121.88M | $10.11M | $9.21M | $8.66M | $8.85M |
| Gross profit | $-4.61M | $-2.40M | $-8.90M | $1.09M | $-75.61M | $-120.01M | $-159.45M | $-110.87M | $40.96M | $3.65M | $113.31M | $108.30M | $33.88M |
| Gross margin | — | — | -5858.6% | 73.5% | -2041.2% | -832.6% | -997.6% | -552.2% | 100.0% | 100.0% | 100.0% | 100.0% | 79.3% |
| R&D | $1.92M | $2.40M | $9.06M | $40.82M | $79.31M | $134.43M | $175.43M | $130.94M | $121.88M | $115.86M | $130.01M | $159.68M | $182.78M |
| SG&A | $1.65M | $3.00M | $10.39M | $15.99M | $26.98M | $39.51M | $48.87M | $42.51M | $46.10M | $50.51M | $51.29M | $59.02M | $75.33M |
| Operating income | $-3.57M | $-5.39M | $-19.30M | $-55.33M | $-102.58M | $-159.52M | $-208.32M | $-153.38M | $-127.02M | $-162.72M | $-68.00M | $-110.40M | $-215.38M |
| Operating margin | — | — | -12696.1% | -3725.7% | -2769.4% | -1106.7% | -1303.4% | -763.9% | -310.1% | -4459.3% | -60.0% | -101.9% | -504.1% |
| EBITDA | $-3.26M | $-5.11M | $-18.56M | $-54.94M | $-100.24M | $-153.94M | $-200.73M | $-145.26M | $-117.18M | $-152.61M | $-58.79M | $-101.74M | $-195.53M |
| EBITDA margin | — | — | -12211.8% | -3699.4% | -2706.2% | -1068.0% | -1255.9% | -723.5% | -286.1% | -4182.1% | -51.9% | -93.9% | -457.6% |
| EBIT | $-3.54M | $-5.39M | $-19.16M | $-55.72M | $-102.39M | $-159.52M | $-208.32M | $-153.38M | $-127.02M | $-162.72M | $-68.00M | $-110.40M | $-204.38M |
| Interest expense | $0.00 | $12000.00 | $86000.00 | $337000.00 | $6000.00 | $22000.00 | $0.00 | $16000.00 | $14.43M | $1.58M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-3.32M | $-5.23M | $-19.20M | $-55.40M | $-102.03M | $-146.65M | $-193.64M | $-149.91M | $-122.25M | $-161.82M | $-57.51M | $-97.01M | $-204.38M |
| Net income growth (YoY) | — | -57.6% | -267.2% | -188.5% | -84.2% | -43.7% | -32.0% | +22.6% | +18.5% | -32.4% | +64.5% | -68.7% | -110.7% |
| Profit margin | — | — | -12631.6% | -3730.7% | -2754.7% | -1017.4% | -1211.5% | -746.7% | -298.4% | -4434.7% | -50.8% | -89.6% | -478.3% |